|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Interest-bearing deposits in banks | ||||||||||||||||||||
| Total cash and cash equivalents | ||||||||||||||||||||
| Securities: | ||||||||||||||||||||
| Available for sale, at fair value: | ||||||||||||||||||||
| Collateralized Traditional Securities | ||||||||||||||||||||
| Property Assessed Clean Energy ("PACE") assessments | ||||||||||||||||||||
| Total available for sale, at fair value: | ||||||||||||||||||||
| Held-to-maturity, at amortized cost | ||||||||||||||||||||
| Collateralized Traditional Securities | ||||||||||||||||||||
| Property Assessed Clean Energy ("PACE") assessments | ||||||||||||||||||||
| Total held-to-maturity, at amortized cost | ||||||||||||||||||||
| Loans held for sale | ||||||||||||||||||||
| Loans receivable, net of deferred loan origination fees and costs | ||||||||||||||||||||
| Allowance for credit losses | ||||||||||||||||||||
| Loans receivable, net | ||||||||||||||||||||
| Resell agreements | ||||||||||||||||||||
| Federal Home Loan Bank of New York ("FHLBNY") stock, at cost | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Bank-owned life insurance | ||||||||||||||||||||
| Right-of-use lease asset | ||||||||||||||||||||
| Deferred tax asset, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Equity method investments | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Deposits | ||||||||||||||||||||
| Subordinated debt, net | ||||||||||||||||||||
| FHLBNY advances | ||||||||||||||||||||
| Borrowings | ||||||||||||||||||||
| Operating leases | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity | ||||||||||||||||||||
| Common stock, par value $0.01 per share (70,000,000 shares authorized; 31,207,172 and 31,045,377 shares issued, respectively, and 29,900,147 and 29,818,424 shares outstanding, respectively) | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss, net of income taxes | ||||||||||||||||||||
| Treasury stock, at cost (1,307,025 and 1,226,953 shares, respectively) | ||||||||||||||||||||
| Total Amalgamated Financial Corp. stockholders' equity | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...